Evidence map›Paper›PMID 12045250›Full record

ReviewThe Journal of experimental medicine2002

Making eosinophils through subtle shifts in transcription factor expression.

Kelly McNagny, Thomas Graf

Abstract readReview
In one paragraph

Review in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Myeloid cells in chronic liver inflammation.Cellular & molecular immunology · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. CCAAT/Enhancer-Binding Protein εInternational journal of molecular sciences · 2021
    Article
  7. Article
  8. Article
  9. Hypereosinophilia: An Unusual Bystander in Cancer.Journal of immunotherapy and precision oncology · 2021
    Article
  10. Review
  11. Review
  12. A novel myeloid cell in murine spleen defined through gene profiling.Journal of cellular and molecular medicine · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. RhoH is a negative regulator of eosinophilopoiesis.Cell death and differentiation · 2016
    Article
  18. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Immunology and allergy clinics of North America · 2016
    Review
  19. The Eosinophil in Health and Disease: from Bench to Bedside and Back.Clinical reviews in allergy & immunology · 2016
    Review
  20. Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kelly McNagnyThe Biomedical Research Centre, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Thomas Graf

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell DifferentiationGene Expression RegulationAnimalsAntigens, CD34CCAAT-Enhancer-Binding Protein-alphaDNA-Binding ProteinsEosinophilsErythroid-Specific DNA-Binding FactorsHumansStem CellsTranscription FactorsAntigens, CD34CCAAT-Enhancer-Binding Protein-alphaDNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsTranscription Factors

Identifiers

PMID12045250
PMCPMC2193544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.